Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Tuesday, February 25th. Analysts expect Guardian Pharmacy Services to post earnings of $0.20 per share for the quarter.
Guardian Pharmacy Services Price Performance
Shares of GRDN opened at $19.58 on Friday. Guardian Pharmacy Services has a 1-year low of $14.16 and a 1-year high of $25.74. The company has a fifty day moving average of $21.09.
Analyst Ratings Changes
Separately, Truist Financial boosted their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a report on Friday, November 15th.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- What is the MACD Indicator and How to Use it in Your Trading
- DuPont’s Electronics Spinoff: The Start of Something Big
- Investing in the High PE Growth Stocks
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
